EyePoint Pharmaceuticals

EyePoint Pharmaceuticals is a specialty biopharmaceutical company committed to developing and commercialising ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. Eyepoint was formerly pSivida.

Headquarters
EyePoint Pharmaceuticals Inc
480 Pleasant Street
Suite B300
Watertown MA 02472
United States

Phone / Contact

T: +1 833 393 7646
F: +1 617 926 5050

Articles by EyePoint Pharmaceuticals

ENVISIONING NEW HORIZONS IN OCULAR DRUG DELIVERY

Jay S Duker discusses the history and future of ocular drug delivery, with a special focus on posterior segment diseases and the battle to overcome significant patient and caregiver burdens.

PSIVIDA AND OPHTHALMIC DRUG DELIVERY

Paul Ashton describes how much of the progress that has been made recently in the treatment of ophthalmic diseases can be ascribed to effective drug delivery systems, and outlines some of the delivery technologies and resulting products for which pSivida has been responsible.

HUGE THERAPEUTIC ADVANCES: BIGGER DRUG DELIVERY OPPORTUNITIES

Paul Ashton gives an introduction into the current state of the ophthalmics market.

Top